Cargando…
Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
BACKGROUND: Human multipotent progenitor cells (hiMPCs) created from induced pluripotent stem cells (iPSCs) represent a new cell source for cartilage regeneration. In most studies, bone morphogenetic proteins (BMPs) are needed to enhance transforming growth factor‐β (TGFβ)‐induced hiMPC chondrogenes...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763539/ https://www.ncbi.nlm.nih.gov/pubmed/36536500 http://dx.doi.org/10.1002/ctm2.1112 |
_version_ | 1784853083375796224 |
---|---|
author | Xiang, Shiqi Lin, Zixuan Makarcyzk, Meagan J. Riewruja, Kanyakorn Zhang, Yiqian Zhang, Xiurui Li, Zhong Clark, Karen L. Li, Eileen Liu, Silvia Hao, Tingjun Fritch, Madalyn R. Alexander, Peter G. Lin, Hang |
author_facet | Xiang, Shiqi Lin, Zixuan Makarcyzk, Meagan J. Riewruja, Kanyakorn Zhang, Yiqian Zhang, Xiurui Li, Zhong Clark, Karen L. Li, Eileen Liu, Silvia Hao, Tingjun Fritch, Madalyn R. Alexander, Peter G. Lin, Hang |
author_sort | Xiang, Shiqi |
collection | PubMed |
description | BACKGROUND: Human multipotent progenitor cells (hiMPCs) created from induced pluripotent stem cells (iPSCs) represent a new cell source for cartilage regeneration. In most studies, bone morphogenetic proteins (BMPs) are needed to enhance transforming growth factor‐β (TGFβ)‐induced hiMPC chondrogenesis. In contrast, TGFβ alone is sufficient to result in robust chondrogenesis of human primary mesenchymal stromal cells (hMSCs). Currently, the mechanism underlying this difference between hiMPCs and hMSCs has not been fully understood. METHODS: In this study, we first tested different growth factors alone or in combination in stimulating hiMPC chondrogenesis, with a special focus on chondrocytic hypertrophy. The reparative capacity of hiMPCs‐derived cartilage was assessed in an osteochondral defect model created in rats. hMSCs isolated from bone marrow were included in all studies as the control. Lastly, a mechanistic study was conducted to understand why hiMPCs and hMSCs behave differently in responding to TGFβ. RESULTS: Chondrogenic medium supplemented with TGFβ3 and BMP6 led to robust in vitro cartilage formation from hiMPCs with minimal hypertrophy. Cartilage tissue generated from this new method was resistant to osteogenic transition upon subcutaneous implantation and resulted in a hyaline cartilage‐like regeneration in osteochondral defects in rats. Interestingly, TGFβ3 induced phosphorylation of both Smad2/3 and Smad1/5 in hMSCs, but only activated Smad2/3 in hiMPCs. Supplementing BMP6 activated Smad1/5 and significantly enhanced TGFβ’s compacity in inducing hiMPC chondrogenesis. The chondro‐promoting function of BMP6 was abolished by the treatment of a BMP pathway inhibitor. CONCLUSIONS: This study describes a robust method to generate chondrocytes from hiMPCs with low hypertrophy for hyaline cartilage repair, as well as elucidates the difference between hMSCs and hiMPCs in response to TGFβ. Our results also indicated the importance of activating both Smad2/3 and Smad1/5 in the initiation of chondrogenesis. |
format | Online Article Text |
id | pubmed-9763539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97635392022-12-20 Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells Xiang, Shiqi Lin, Zixuan Makarcyzk, Meagan J. Riewruja, Kanyakorn Zhang, Yiqian Zhang, Xiurui Li, Zhong Clark, Karen L. Li, Eileen Liu, Silvia Hao, Tingjun Fritch, Madalyn R. Alexander, Peter G. Lin, Hang Clin Transl Med Research Articles BACKGROUND: Human multipotent progenitor cells (hiMPCs) created from induced pluripotent stem cells (iPSCs) represent a new cell source for cartilage regeneration. In most studies, bone morphogenetic proteins (BMPs) are needed to enhance transforming growth factor‐β (TGFβ)‐induced hiMPC chondrogenesis. In contrast, TGFβ alone is sufficient to result in robust chondrogenesis of human primary mesenchymal stromal cells (hMSCs). Currently, the mechanism underlying this difference between hiMPCs and hMSCs has not been fully understood. METHODS: In this study, we first tested different growth factors alone or in combination in stimulating hiMPC chondrogenesis, with a special focus on chondrocytic hypertrophy. The reparative capacity of hiMPCs‐derived cartilage was assessed in an osteochondral defect model created in rats. hMSCs isolated from bone marrow were included in all studies as the control. Lastly, a mechanistic study was conducted to understand why hiMPCs and hMSCs behave differently in responding to TGFβ. RESULTS: Chondrogenic medium supplemented with TGFβ3 and BMP6 led to robust in vitro cartilage formation from hiMPCs with minimal hypertrophy. Cartilage tissue generated from this new method was resistant to osteogenic transition upon subcutaneous implantation and resulted in a hyaline cartilage‐like regeneration in osteochondral defects in rats. Interestingly, TGFβ3 induced phosphorylation of both Smad2/3 and Smad1/5 in hMSCs, but only activated Smad2/3 in hiMPCs. Supplementing BMP6 activated Smad1/5 and significantly enhanced TGFβ’s compacity in inducing hiMPC chondrogenesis. The chondro‐promoting function of BMP6 was abolished by the treatment of a BMP pathway inhibitor. CONCLUSIONS: This study describes a robust method to generate chondrocytes from hiMPCs with low hypertrophy for hyaline cartilage repair, as well as elucidates the difference between hMSCs and hiMPCs in response to TGFβ. Our results also indicated the importance of activating both Smad2/3 and Smad1/5 in the initiation of chondrogenesis. John Wiley and Sons Inc. 2022-12-19 /pmc/articles/PMC9763539/ /pubmed/36536500 http://dx.doi.org/10.1002/ctm2.1112 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Xiang, Shiqi Lin, Zixuan Makarcyzk, Meagan J. Riewruja, Kanyakorn Zhang, Yiqian Zhang, Xiurui Li, Zhong Clark, Karen L. Li, Eileen Liu, Silvia Hao, Tingjun Fritch, Madalyn R. Alexander, Peter G. Lin, Hang Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells |
title | Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells |
title_full | Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells |
title_fullStr | Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells |
title_full_unstemmed | Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells |
title_short | Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells |
title_sort | differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and ipsc‐derived multipotent cells |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763539/ https://www.ncbi.nlm.nih.gov/pubmed/36536500 http://dx.doi.org/10.1002/ctm2.1112 |
work_keys_str_mv | AT xiangshiqi differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT linzixuan differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT makarcyzkmeaganj differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT riewrujakanyakorn differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT zhangyiqian differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT zhangxiurui differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT lizhong differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT clarkkarenl differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT lieileen differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT liusilvia differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT haotingjun differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT fritchmadalynr differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT alexanderpeterg differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells AT linhang differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells |